About
About QT Vascular Ltd
QT Vascular Ltd., together with its subsidiaries, engages in the design, assembly, and distribution of advanced therapeutic solutions for the minimally invasive treatment of complex vascular diseases. The company provides coronary products, including Chocolate percutaneous transluminal coronary angioplasty (PTCA) balloon catheter to reduce vessel trauma by providing balloon inflation; and Glider PTCA balloon catheter for the treatment of various complex lesions. It also offers Chocolate percutaneous transluminal angioplasty (PTA) balloon catheter for atraumatic dilatation in the treatment of blocked arteries; Chocolate Touch PTA balloon catheter to treat peripheral vascular disease; GliderfleX PTA balloon catheter for treating distal peripheral vessels; and GliderXtreme PTA balloon catheter that targets complex lesions in the distal peripheral vasculature. In addition, it offers dental and management consultancy services for healthcare organizations. The company has operations in the United States, Europe, and Singapore. QT Vascular Ltd. was incorporated in 2005 and is based in Singapore.
Visit company website
5 years, 5 months ago
QT Vascular Ltd is currently in a long term downtrend where the price is trading 30.7% below its 200 day moving average.
From a valuation standpoint, the stock is 63.4% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.1.
QT Vascular Ltd's total revenue sank by 36.2% to $557K since the same quarter in the previous year.
Its net income has dropped by 209.6% to $-8M since the same quarter in the previous year.
Finally, its free cash flow fell by 61.1% to $-2M since the same quarter in the previous year.
Based on the above factors, QT Vascular Ltd gets an overall score of 1/5.